Roche Articles
Japan stock market week to April 27, 2009
28 April 2009
Roche to trial Tarceva in EGFR lung cancer
28 April 2009
"Perverse" NICE again says "No" to new drugs
28 April 2009
Stock Commentary - Europe - week to April 20, 2009
23 April 2009
GSK France welcomes alli launch OK from EC
22 April 2009
BioInvent cuts 1st-qtr loss on Roche milestone
21 April 2009
Roche announces details of Genentech management shake-up
16 April 2009
Stock Commentary - Europe - week to April 13, 2009
16 April 2009
Paion's anesthetic enters Ph II trial
15 April 2009
AZ eyeing up small European firms
15 April 2009
SCLC drug market wil more than double to $648M in 2017
14 April 2009
SAP potential new drug target for Alzheimer's
14 April 2009
Stock Commentary - Europe - week to Aug 15
8 April 2009
Stock Commentary - Europe - week to mar 30, 2009
2 April 2009
EMEA Avastin label
1 April 2009
Roche microarrays further ALL knowledge
1 April 2009
India steps up bird flu detection efforts
31 March 2009
Japan stock market week to March 30, 2009
31 March 2009
GSK appeals UK's NICE refusal for Tyverb
30 March 2009
Roche completes tender offer for Genentech
30 March 2009
Stock Commentary - Europe - week to March 23, 2009
30 March 2009
DxS gets CE mark for TheraScreen K-RAS kit
30 March 2009
Sutent cleared for UK kidney cancer patients
30 March 2009
OSI submits Tarceva in Europe and USA
30 March 2009
Cilengitide "promotes cancer growth"
30 March 2009
Strong Ph III data for Herceptin in stomach cancer
23 March 2009
Advantages of telaprevir- and boceprevir-based regimens
23 March 2009
Stock Commentary - Europe - week to Mar 16, 2009
23 March 2009
Transgene 2008 loss up four-fold
23 March 2009
ThromboGenics swings to profit on Roche deal
23 March 2009
Stock Commentary - Europe - week to Mar 9, 2009
16 March 2009
Stock Commentary - New York week to Mar 9, 2009
16 March 2009
Genentech accepts Roche $95/share bid
16 March 2009
"90% four-year survival" with Herceptin
16 March 2009
Synosia announces 2nd CNS deal with Roche
16 March 2009
HGS/Novartis drug non- inferior to Pegasys
16 March 2009
Evotec signs $300M deal with Roche; rises 15%
16 March 2009
Roche upped bid still gets Genentech's "no"
16 March 2009
Stock Commentary - Europe - week to mar 2, 2009
9 March 2009
Roche found guilty of UK Code violation again
9 March 2009
New guidelines to help boost use of 5-ARIs
9 March 2009
Agility and innovation, at Economist
9 March 2009
Alnylam cuts 2008 loss, but falls back in 4th qtr
9 March 2009
Roche's MabThera approved for CLL
9 March 2009
Roche raises further $14B in bonds to buy Genentech
2 March 2009
Stock Commentary - New York week to Feb 23, 2009
2 March 2009
Detailed results on BioCryst's peramivir
2 March 2009
Genentech advises shareholders to reject Roche's $86.50 per share bid; growing hostility
2 March 2009
Profit soars for OSI on income tax credit
2 March 2009
Chugai licenses Japanese rights to Romark's HCV drug nitazoxanide
23 February 2009
Roche sells $16B of bonds to finance renewed Genentech bid
23 February 2009
Action Pharma names Torben Laursen as VP of business development
23 February 2009
PDCO gives go ahead for 13 new PIPs
23 February 2009
Roche's Valcyte works up to 200 days; trial
23 February 2009
Roche reinstated to ABPI membership
23 February 2009
Roche goes hostile in bid for Genentech, offering $86.50 a share
16 February 2009
UPDATE: Dutch NGO's CT claims rebutted by GSK and AZ
16 February 2009
Stock Commentary - Europe - week to Feb 9, 2009
16 February 2009
Dutch NGO's CT claims rebutted by GSK
16 February 2009
Sutent available in England, not Scotland
9 February 2009
CellCentric recruits Piramed's David Knowles and Neil Pegg
9 February 2009
Stock Commentary - Europe - week to Feb 2, 2009
9 February 2009
Roche's profit falls 5% on lower Tamiflu sales
9 February 2009
OSI shares jump 11.4% on Tarceva/Avastin benefit in NSCLC
9 February 2009
Roche goes hostile, lowers Genentech bid
9 February 2009
EC approves GSK's OTC orlistat product alli
26 January 2009
Qiagen appoints Tom Clements as VP
26 January 2009
Japan stock market week to Jan 19, 2009
26 January 2009
More job cuts among Big Pharma firms
26 January 2009
Highlights of first PDCO meeting of 2009
26 January 2009
Roche GI cancer therapy as good as FOLFOX
26 January 2009
Halozyme earns milestone from Roche
26 January 2009
Taisho and GSK to develop orlistat in Japan
26 January 2009
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
